Giles K, et al. Real-world efficacy of delayed-release dimethyl fumarate in early multiple sclerosis: interim results from ESTEEM. ECTRIMS 2018, P595.
Licht verhoogd risico op guillain-barrésyndroom na griepvaccinatie
sep 2022 | Vaccinatie
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen